Literature DB >> 19009862

Laparoscopic nephron sparing surgery: a multi-institutional European survey of 592 cases.

Antonio Celia1, Guglielmo Zeccolini, Giorgio Guazzoni, Vito Pansadoro, Vincenzo Disanto, Francesco Porpiglia, Claudio Milani, Claude Abbou, Richard Gaston, Gunter Janetschek, Naeem A Soomroo, P Fornara, Alberto Breda, Peter G Schulam, Jean De la Rosette, M Pilar Laguna, Jean Palou, Guglielmo Breda.   

Abstract

Laparoscopic Nephron Sparing Surgery (LNSS) is a technically challenging procedure. Technical aspects and the outcome of LNSS are investigated. A total of 592 LNSS procedures were collected from 12 Centres, either in extraperitoneal or transperitoneal fashion. Mean tumor size was 2.2 cm. Eight centers reported on tumor position for a total of 407 cases with 338 exophytic tumors (83%) and 69 deep lesions (17%). Four centers, accounting for 185 cases, did not report on tumor position. All the centers performed their LNSS by clamping the hilum. The warm ischemia time was < 30 min in all the centers. The positive margin rate was 2% (12/592). Hemostatic agents and/or sealant or tissue glues were used in 86% of cases (511/592). Types of sealants used included: gelatine matrix (Floseal), fibrin gel (Tissucol), bovine serum albumin (BioGlue) and cianacrylate (Glubran). Two Centres never used sealants, one center used only sealants without suturing and 9 centers used a combination of sealants and bolstering-sutures. The intraoperative open conversion rate was 3.5% (21/592). Postoperative complications included bleeding in 15/592 (2.5%) and urine leak in 13/592 (2.1%). No tumor seeding was reported. LNSS has similar results of open partial nephrectomy. The use of hemostatic agents and/or sealants or tissue glues during LNSS is largely diffuse in European centers and may be an effective add on reducing bleeding and urine leakage when used in combination with bolstering-suturing.

Entities:  

Mesh:

Year:  2008        PMID: 19009862

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  7 in total

1.  Current Status of Hemostatic Agents and Sealants in Urologic Surgical Practice.

Authors:  Sashi S Kommu; Robert McArthur; Amr M Emara; Utsav D Reddy; Christopher J Anderson; Neil J Barber; Raj A Persad; Christopher G Eden
Journal:  Rev Urol       Date:  2015

2.  Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes.

Authors:  Venu Chalasani; Carlos H Martinez; Darwin Lim; Mazen Abdelhady; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

3.  Bovine serum albumin glutaraldehyde for completely sutureless laparoscopic heminephrectomy in a survival porcine model.

Authors:  Michael K Louie; Aldrin Joseph R Gamboa; Adam G Kaplan; Amanda Khosravi; Hung Truong; Lorena Andrade; Rachelle Lin; Reza Alipanah; Cervando Ortiz; David McCormick; Geoffrey N Box; Hak J Lee; Leslie A Deane; Robert A Edwards; Elspeth M McDougall; Ralph V Clayman
Journal:  J Endourol       Date:  2010-03       Impact factor: 2.942

4.  Haemostatics in surgery and our experience in the enucleoresection of renal cell carcinoma.

Authors:  Gianna Pace; Pietro Saldutto; Carlo Vicentini; Lucio Miano
Journal:  World J Surg Oncol       Date:  2010-05-12       Impact factor: 2.754

5.  Multicenter experience with nonischemic multiport laparoscopic and laparoendoscopic single-site partial nephrectomy utilizing bipolar radiofrequency ablation coagulator.

Authors:  Wassim M Bazzi; Mohamad E Allaf; Jared Berkowitz; Hany N Atalah; Sijo Parekattil; Ithaar H Derweesh
Journal:  Diagn Ther Endosc       Date:  2011-06-20

6.  Use of biological Glue (Bioglue®) in laparoscopic partial nephrectomy: a study in pigs.

Authors:  Luis Felipe Brandão; Fabio Cesar Miranda Torricelli; Glauco Melo; Luiz Cesar Fernando Takano; Anuar Ibrahim Mitre; Marco Antonio Arap
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

7.  Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia time.

Authors:  Hagen Loertzer; Arne Strauß; Rolf Herrmann Ringert; Philine Schneider
Journal:  BMC Urol       Date:  2013-06-20       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.